Could a common parasite drug help young kids with scabies?

NCT ID NCT04332068

Completed Disease control Sponsor: University of Oxford Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested the safety and effectiveness of oral ivermectin for treating scabies in children weighing 5 to less than 15 kilograms. 240 children participated, receiving either ivermectin, a standard permethrin cream, or a placebo. The goal is to see if ivermectin can be a safe and effective treatment option for this young age group.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: ivermectin (oral tablet)
What this could lead to: If successful, this could provide a safe and effective oral treatment for scabies in young children, expanding access to care.
What could go wrong: This is a Phase 2 trial with a relatively small number of participants. The results may not confirm safety or efficacy, and side effects are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SCABIES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

scabies

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SCABIES

Contacts and locations

Locations

Alfredo da Matta Tropical Dermatology Foundation (FUAM)

Manaus, Brazil
Kenya Medical Research Institute

Kisumu, Kenya
MRC Unit The Gambia

Banjul, The Gambia

More trials for these conditions

Other studies related to the condition(s) this trial covers.